Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	answer text question first answered answering member label
creator	label
publisher
tabling member	label

Search

1354564

	human indexable
	published
	registered interest
	answer date	14/09/2021
	date	10/09/2021
	date tabled	10/09/2021
	ddp created	10/09/2021 15:03:33
	answering body	Department for Business, Energy and Industrial Strategy
	question status	Tabled
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	ddp modified	10/09/2021 15:10:36 20/09/2021 16:07:07
	hansard heading	Regional Planning and Development: Science and Research
	house id	1
	identifier	47052
	legislature	25259
	parliament number	58
	question first answered	20/09/2021 15:35:22
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps he is taking to prioritise science and research in the levelling up agenda in (a) Newport West constituency, (b) Wales and (c) the UK.
	session	2021/22
	session number	2
	tabling member constituency	Newport West
	tabling member printed	Ruth Jones
	title	House of Commons Tabled Parliamentary Question 2021/22 47052
	type	WrittenParliamentaryQuestion
	uin	47052
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>We recognise the need to take a comprehensive place-based approach to economic growth, that responds to the varying needs of places. We will publish a detailed approach for levelling up through R&amp;D as part of the forthcoming Levelling Up White Paper.</p><p> </p><p>Ahead of then, UKRI’s Strength in Places Fund (SIPF) is the first major national competitive R&amp;D fund that takes a place-based approach contributing to the Government’s wider levelling up ambitions. In June 2020, BEIS announced an award of £25m to the CS Connected project in the first wave of SIPF, to develop South Wales’ compound semiconductor cluster. Project partners are from across the region including Newport. This summer, BEIS announced a £22m award to the media.cymru project to develop Cardiff’s media cluster.</p> question first answered 20/09/2021 15:35:22 answering member 4020 label Biography information for George Freeman
	creator	4716 label Biography information for Ruth Jones
	publisher	25259
	tabling member	4716 label Biography information for Ruth Jones

1355302

	human indexable
	published
	registered interest
	answer date	20/09/2021
	date	14/09/2021
	date tabled	14/09/2021
	ddp created	14/09/2021 20:17:05
	answering body	Department for Business, Energy and Industrial Strategy
	question status	Tabled
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	ddp modified	14/09/2021 20:26:56 20/09/2021 16:04:15
	hansard heading	Department for Business, Energy and Industrial Strategy: Listed Buildings
	house id	1
	identifier	49013
	legislature	25259
	parliament number	58
	question first answered	20/09/2021 15:32:47
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, pursuant to the Answer of 10 September 2021 to Question 44165 on Department for Business, Energy and Industrial Strategy: Listed Buildings, if he will publish a list of the (a) properties classified as heritage assets owned by his Department, (b) the most recent estimate of the value of those properties and (c) the annual income derived from those properties as opposed to the details of the body responsible for advising him on those properties' management.
	session	2021/22
	session number	2
	tabling member constituency	East Worthing and Shoreham
	tabling member printed	Tim Loughton
	title	House of Commons Tabled Parliamentary Question 2021/22 49013
	type	WrittenParliamentaryQuestion
	uin	49013
	version	1
	written parliamentary question type	NamedDay
	answer	answer answer text <p>The following table provides a list of heritage assets recorded by the Department for Business, Energy and Industrial Strategy, alongside valuation and income data where available:</p><p> </p><table><tbody><tr><td><p><strong>Property</strong></p></td><td><p><strong>Annual Income</strong></p></td><td><p><strong>Valuation 31.03.21</strong></p></td></tr><tr><td><p>Pelham House (ID 1356190), <br>Pelham House North Lodge (ID 1086590), <br>Pelham House South Lodge (ID 1356193)</p></td><td><p>£120,051</p></td><td><p>£1,045,000</p></td></tr><tr><td><p>Calder Farm Stangs Cottage (ID 1068621)</p></td><td><p>£0</p></td><td><p>£150,000</p></td></tr><tr><td><p>Seascale Hall (ID 13360641)</p></td><td><p>£16,000</p></td><td><p>£1,000,000</p></td></tr><tr><td><p>Berkeley Summerhouse (ID 1274730)</p></td><td><p>£0</p></td><td><p>£1</p></td></tr><tr><td><p>Seascale Farm stone circle</p></td><td><p>£0</p></td><td><p>£0</p></td></tr><tr><td><p>Bushy House (ID 1089870)</p></td><td><p>£0</p></td><td><p>n/a</p></td></tr><tr><td><p>Dounreay Castle (ID SM6401)</p></td><td><p>£0</p></td><td><p>n/a</p></td></tr><tr><td><p>Cnoc-na-h’Uiseig Chambered Cairn (ID SM444)</p></td><td><p>£0</p></td><td><p>n/a</p></td></tr><tr><td><p>Knock Stanger Cairn (ID SM458)</p></td><td><p>£0</p></td><td><p>n/a</p></td></tr><tr><td><p>Dragon Square Garden (ID 422271)</p></td><td><p>£0</p></td><td><p>n/a</p></td></tr><tr><td><p>Dame Sylvia Crowe Garden (ID 422272)</p></td><td><p>£0</p></td><td><p>n/a</p></td></tr><tr><td><p>Cestyll Garden (ID 301555)</p></td><td><p>£0</p></td><td><p>n/a</p></td></tr></tbody></table> question first answered 20/09/2021 15:32:47 answering member 4020 label Biography information for George Freeman
	creator	114 label Biography information for Tim Loughton
	publisher	25259
	tabling member	114 label Biography information for Tim Loughton

101761

	human indexable
	published
	registered interest
	answer date	03/11/2014
	date	30/10/2014
	date tabled	30/10/2014
	ddp created	30/10/2014 22:00:42
	ddp modified	08/02/2015 05:18:58
	answering body	Department for Business, Innovation and Skills
	question status	Tabled
	answering dept id	26
	answering dept short name	Business, Innovation and Skills
	answering dept sort name	Business, Innovation and Skills
	hansard heading	Biotechnology
	house id	1
	identifier	212639
	legislature	25259
	parliament number	55
	question first answered	07/11/2014 16:53:00
	question text	To ask the Secretary of State for Business, Innovation and Skills, what estimate he has made of the number of jobs in each region and constituent part of the UK which are supported by the life science industry.
	session	2014/15
	session number	4
	tabling member constituency	Salisbury
	tabling member printed	John Glen
	title	House of Commons Tabled Parliamentary Question 2014/15 212639
	type	WrittenParliamentaryQuestion
	uin	212639
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>There are no published official statistics on the regional distribution of life science industry jobs. The table below includes an estimate of employment in 2013 in companies active in three “health life science” sectors: Medical Biotechnology, Medical Technology and Pharmaceuticals, by region and by constituent part of the UK, obtained from the Bioscience and Health Technology company database used by the Office for Life Sciences. The figures are based on locations of active sites for which employment figures can be obtained. They do not include those employed by public or third sector organisations nor employment in companies whose main activity falls outside life sciences, including indirect suppliers to the sector.</p><p> </p><table><tbody><tr><td> </td><td><p><strong>Number of employees in health life science industry ‘000s 2013</strong></p></td></tr><tr><td><p>East Midlands</p></td><td><p>9.5</p></td></tr><tr><td><p>East of England</p></td><td><p>28.8</p></td></tr><tr><td><p>Greater London</p></td><td><p>13.6</p></td></tr><tr><td><p>North East England</p></td><td><p>7.1</p></td></tr><tr><td><p>North West England</p></td><td><p>17.0</p></td></tr><tr><td><p>South East England</p></td><td><p>36.8</p></td></tr><tr><td><p>South West England</p></td><td><p>8.2</p></td></tr><tr><td><p>West Midlands</p></td><td><p>14.5</p></td></tr><tr><td><p>Yorkshire and the Humber</p></td><td><p>13.5</p></td></tr><tr><td><p>England total</p></td><td><p>149.0</p></td></tr><tr><td> </td><td> </td></tr><tr><td><p>Northern Ireland</p></td><td><p>4.3</p></td></tr><tr><td><p>Scotland</p></td><td><p>11.5</p></td></tr><tr><td><p>Wales</p></td><td><p>9.1</p></td></tr><tr><td><p>UK Total</p></td><td><p>173.9</p></td></tr></tbody></table><p>Source: Bioscience and Health Technology database, an annual summary of the data was published as “Strength and Opportunity 2013, the landscape of the medical technology, medical biotechnology, industrial biotechnology and pharmaceutical sectors in the UK”</p><p> </p><p> </p><p> </p> question first answered 07/11/2014 16:53:00 answering member 4020 label Biography information for George Freeman
	creator	4051 label Biography information for John Glen
	publisher	25259
	tabling member	4051 label Biography information for John Glen

101774

	human indexable
	published
	registered interest
	answer date	03/11/2014
	date	30/10/2014
	date tabled	30/10/2014
	ddp created	30/10/2014 22:00:46
	ddp modified	08/02/2015 05:20:24
	answering body	Department for Business, Innovation and Skills
	question status	Tabled
	answering dept id	26
	answering dept short name	Business, Innovation and Skills
	answering dept sort name	Business, Innovation and Skills
	hansard heading	Biotechnology
	house id	1
	identifier	212635
	legislature	25259
	parliament number	55
	question first answered	11/11/2014 12:46:09
	question text	To ask the Secretary of State for Business, Innovation and Skills, what comparative assessment he has made of the competitiveness of the (a) UK, (b) France, (c) Germany, (d) China and (e) US life science industry.
	session	2014/15
	session number	4
	tabling member constituency	Salisbury
	tabling member printed	John Glen
	title	House of Commons Tabled Parliamentary Question 2014/15 212635
	type	WrittenParliamentaryQuestion
	uin	212635
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>The UK pharmaceutical sector contributes more than £13 billion to UK Gross Value Added (GVA), making it the second largest in Europe after Germany measured by GVA. The life sciences sector employs 173,900 people in the UK, and the UK is second only to the US measured by the share of top 1% citations in life science related subjects. The Office of Life Sciences is currently developing a set of indicators reflecting the broad competitiveness of the UK life science environment against key international comparators.</p><p> </p><p>More broadly, the most recent Global Competitiveness Report by the World Economic Forum (WEF) overall ranks the UK within the top 10 competitive countries in which to conduct business, continuing its historical strong performance. The UK is well regarded for its high quality science and research base, high-level skills, openness to international trade and effectiveness of its regulatory and competition regimes and flexible labour market. As a result the UK overall remains a magnet for inward investment, second only to the USA.</p><p> </p> question first answered 11/11/2014 12:46:09 answering member 4020 label Biography information for George Freeman
	creator	4051 label Biography information for John Glen
	publisher	25259
	tabling member	4051 label Biography information for John Glen

101775

	human indexable
	published
	registered interest
	answer date	03/11/2014
	date	30/10/2014
	date tabled	30/10/2014
	ddp created	30/10/2014 22:00:47
	ddp modified	08/02/2015 05:20:30
	answering body	Department for Business, Innovation and Skills
	question status	Tabled
	answering dept id	26
	answering dept short name	Business, Innovation and Skills
	answering dept sort name	Business, Innovation and Skills
	hansard heading	Biotechnology
	house id	1
	identifier	212636
	legislature	25259
	parliament number	55
	question first answered	11/11/2014 11:48:16
	question text	To ask the Secretary of State for Business, Innovation and Skills, what structures his Department has in place to ensure that (a) the Life Sciences Organisation and (b) the Office for Life Sciences co-ordinate with the MHRA and National Institute of Health and Care Excellence.
	session	2014/15
	session number	4
	tabling member constituency	Salisbury
	tabling member printed	John Glen
	title	House of Commons Tabled Parliamentary Question 2014/15 212636
	type	WrittenParliamentaryQuestion
	uin	212636
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>Since April 2014 the Office for Life Sciences (OLS) has operated as a joint Director-led unit between the Department of Business Innovation and Skills and the Department of Health. The previous good working relationships between the OLS and MHRA and NICE have been strengthened through this move, as all these bodies are now either part of or sponsored by the Department of Health and all three fall within my Ministerial portfolio.</p><p> </p><p>The UKTI Life Sciences Organisation (LSO) also has strong working relationships with MHRA and NICE, both directly and through the OLS, largely operating on an informal basis rather than within particular structures.</p><p> </p> question first answered 11/11/2014 11:48:16 answering member 4020 label Biography information for George Freeman
	creator	4051 label Biography information for John Glen
	publisher	25259
	tabling member	4051 label Biography information for John Glen

156915

	human indexable
	published
	registered interest
	answer date	25/11/2014
	date	20/11/2014
	date tabled	20/11/2014
	ddp created	20/11/2014 20:10:25
	ddp modified	08/02/2015 10:34:22
	answering body	Department for Business, Innovation and Skills
	question status	Tabled
	answering dept id	26
	answering dept short name	Business, Innovation and Skills
	answering dept sort name	Business, Innovation and Skills
	hansard heading	Bayer
	house id	1
	identifier	215405
	legislature	25259
	parliament number	55
	question first answered	25/11/2014 13:46:31
	question text	To ask the Secretary of State for Business, Innovation and Skills, what meetings (a) he and (b) officials in his Department have had with Bayer plc in the last five years.
	session	2014/15
	session number	4
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	title	House of Commons Tabled Parliamentary Question 2014/15 215405
	type	WrittenParliamentaryQuestion
	uin	215405
	version	1
	written parliamentary question type	NamedDay
	answer	answer answer text <p>Details of Ministers’ meetings with external organisations are published quarterly on the Gov.uk website:</p><p> </p><p> </p><p> </p><p><a href="https://www.gov.uk/government/publications?departments%5B%5D=department-for-business-innovation-skills&amp;publication_type=transparency-data" target="_blank">https://www.gov.uk/government/publications?departments%5B%5D=department-for-business-innovation-skills&amp;publication_type=transparency-data</a></p><p> </p><p> </p><p> </p><p>Information for April – June 2014 is due to be published soon.</p><p> </p><p>Details of meetings with officials are not held centrally and could only be provided at disproportionate cost.</p><p> </p><p> </p><p> </p> question first answered 25/11/2014 13:46:31 answering member 4020 label Biography information for George Freeman
	creator	3924 label Biography information for Yasmin Qureshi
	publisher	25259
	tabling member	3924 label Biography information for Yasmin Qureshi

166930

	human indexable
	published
	registered interest
	answer date	03/12/2014
	date	01/12/2014
	date tabled	01/12/2014
	ddp created	02/12/2014 01:10:31
	ddp modified	08/02/2015 12:42:13
	answering body	Department for Business, Innovation and Skills
	question status	Tabled
	answering dept id	26
	answering dept short name	Business, Innovation and Skills
	answering dept sort name	Business, Innovation and Skills
	hansard heading	Animal Experiments
	house id	1
	identifier	216683
	legislature	25259
	parliament number	55
	question first answered	08/12/2014 14:56:42
	question text	To ask the Secretary of State for Business, Innovation and Skills, what research his Department has commissioned on the contribution of testing households products and their ingredients on animals to the UK economy; and if he will make a statement.
	session	2014/15
	session number	4
	tabling member constituency	Derby North
	tabling member printed	Chris Williamson
	title	House of Commons Tabled Parliamentary Question 2014/15 216683
	type	WrittenParliamentaryQuestion
	uin	216683
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>The Department for Business, Innovation &amp; Skills has not commissioned research on the contribution of testing household products and their ingredients on animals to the UK economy.</p><p> </p><p> </p><p> </p><p>Animal testing in the UK is licensed through the Home Office.</p><p> </p> question first answered 08/12/2014 14:56:42 answering member 4020 label Biography information for George Freeman
	creator	3976 label Biography information for Chris Williamson
	publisher	25259
	tabling member	3976 label Biography information for Chris Williamson

167391

	human indexable
	published
	registered interest
	answer date	04/12/2014
	date	02/12/2014
	date tabled	02/12/2014
	ddp created	02/12/2014 23:40:25
	ddp modified	08/02/2015 13:14:00
	answering body	Department for Business, Innovation and Skills
	question status	Tabled
	answering dept id	26
	answering dept short name	Business, Innovation and Skills
	answering dept sort name	Business, Innovation and Skills
	hansard heading	Tuberculosis: Vaccination
	house id	1
	identifier	216738
	legislature	25259
	parliament number	55
	question first answered	09/12/2014 11:14:42
	question text	To ask the Secretary of State for Business, Innovation and Skills, what support his Department provides to research into finding new vaccines for antibiotic resistant strains of TB; and if he will make a statement.
	session	2014/15
	session number	4
	tabling member constituency	Brighton, Kemptown
	tabling member printed	Simon Kirby
	title	House of Commons Tabled Parliamentary Question 2014/15 216738
	type	WrittenParliamentaryQuestion
	uin	216738
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>The Department for Business, Innovation and Skills supports research into TB through the UK Research Councils who support a broad portfolio of research addressing different aspects of the disease. This includes research on vaccines and treatments for antibiotic resistant strains of TB.</p><p> </p><p>The Medical Research Council (MRC) currently supports five projects directly relating to antibiotic resistant strains of TB with a total value of £5.7m. These include studies which aim to identify novel targets for antibacterial drug discovery, the development of new TB vaccines and antibiotics, clinical trials with a focus on translational and implementation research relevant to developing countries, and health services and health systems research.</p><p> </p><p>The MRC is also leading an anti-microbial resistance (AMR) funders’ forum to coordinate activities in this area and an initiative involving all of the UK Research Councils on which aims to tackle resistance and try to develop treatments and diagnostic tools. In addition the MRC also supports a broader portfolio of research into TB likely to improve our understanding and inform future research into antibiotic resistant strains.</p><p> </p><p>The Biotechnology and Biological Sciences Research Council (BBSRC) are funding research into new treatments for antibiotic resistant strains of TB in addition to research on vaccine development, which while not specifically addressing antibiotic resistant strains is likely to improve our understanding and inform future research.</p><p> </p><p>An Economic and Social Research Council (ESRC) funded study aims identify barriers to tuberculosis diagnosis and treatment uptake while an EPSRC fellowship is looking at the transmission dynamics of TB.</p><p> </p><p>Researchers are also using the Diamond Light Source, to identify ways of disabling the enzyme that protects the TB bacteria and to understand the structure of the protein that enables the TB bacteria to survive in the human body. It is hoped that this work will make existing treatments easier and more effective and to help design new drugs. The Diamond Light Source is the UK’s national synchrotron, funded by the Science and Technology Facilities Council (STFC).</p><p> </p><p>The UK is also a member of the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis, malaria and other neglected diseases. In December 2014 the second phase of the partnership, EDCTP2 was launched aiming to contribute over 1billion euros over the next 10 years. Further information can be found at: <a href="http://www.edctp.org/" target="_blank">http://www.edctp.org/</a></p> question first answered 09/12/2014 11:14:42 answering member 4020 label Biography information for George Freeman
	creator	3929 label Biography information for Simon Kirby
	publisher	25259
	tabling member	3929 label Biography information for Simon Kirby

167392

	human indexable
	published
	registered interest
	answer date	04/12/2014
	date	02/12/2014
	date tabled	02/12/2014
	ddp created	02/12/2014 23:40:25
	ddp modified	08/02/2015 13:14:09
	answering body	Department for Business, Innovation and Skills
	question status	Tabled
	answering dept id	26
	answering dept short name	Business, Innovation and Skills
	answering dept sort name	Business, Innovation and Skills
	hansard heading	Ebola
	house id	1
	identifier	216739
	legislature	25259
	parliament number	55
	question first answered	09/12/2014 14:19:58
	question text	To ask the Secretary of State for Business, Innovation and Skills, what support his Department provides to research into finding a cure for Ebola; and if he will make a statement.
	session	2014/15
	session number	4
	tabling member constituency	Brighton, Kemptown
	tabling member printed	Simon Kirby
	title	House of Commons Tabled Parliamentary Question 2014/15 216739
	type	WrittenParliamentaryQuestion
	uin	216739
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>The Department for Business, Innovation and Skills supports research into Ebola through the UK Research Councils who support a number of research projects addressing different aspects of the disease. This includes work on vaccines, treatments and interventions, and finding a cure.</p><p> </p><p>Current Medical Research Council (MRC) funded research includes a £2.8m grant funding jointly by the MRC, the Wellcome Trust and DFID to allow a team led by the University of Oxford to test the safety of a candidate vaccine alongside similar trials in the US.</p><p> </p><p>The MRC Centre for Outbreak Analysis and Modelling, at Imperial College London, is an official WHO Collaborating Centre for Infectious Disease Modelling. Researchers there have been providing advice to the WHO regarding the current Ebola outbreak in West Africa and contributed to a study reviewing data since the beginning of the outbreak in December 2013 to determine the scale of the epidemic, better understand the spread of the disease, and explore what it will take to reverse the trend of infections.</p><p> </p><p>The Economic and Social Research Council (ESRC) is supporting one £3.6m study which aims to improve our understanding of the cultural and political dimension to inform interventions. In addition researchers funded by the Science and Technology Facilities Council (STFC) are using the Diamond Light Source to investigate emerging viruses are making an Ebola protein for therapeutic antibodies. The Diamond Light Source is the UK’s national synchrotron and is also funded by STFC.</p><p> </p><p>The UK is also a member of the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis, malaria and other neglected diseases, including Ebola. In December 2014 the second phase of the partnership, EDCTP2 was launched aiming to contribute over 1billion euros over the next 10 years. Further information can be found at: <a href="http://www.edctp.org/" target="_blank">http://www.edctp.org/</a></p><p> </p> question first answered 09/12/2014 14:19:58 answering member 4020 label Biography information for George Freeman
	creator	3929 label Biography information for Simon Kirby
	publisher	25259
	tabling member	3929 label Biography information for Simon Kirby

167393

	human indexable
	published
	registered interest
	answer date	04/12/2014
	date	02/12/2014
	date tabled	02/12/2014
	ddp created	02/12/2014 23:40:26
	ddp modified	08/02/2015 13:14:14
	answering body	Department for Business, Innovation and Skills
	question status	Tabled
	answering dept id	26
	answering dept short name	Business, Innovation and Skills
	answering dept sort name	Business, Innovation and Skills
	hansard heading	Ebola: Vaccination
	house id	1
	identifier	216740
	legislature	25259
	parliament number	55
	question first answered	09/12/2014 14:19:58
	question text	To ask the Secretary of State for Business, Innovation and Skills, what support his Department provides to research into finding a vaccine for Ebola; and if he will make a statement.
	session	2014/15
	session number	4
	tabling member constituency	Brighton, Kemptown
	tabling member printed	Simon Kirby
	title	House of Commons Tabled Parliamentary Question 2014/15 216740
	type	WrittenParliamentaryQuestion
	uin	216740
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>The Department for Business, Innovation and Skills supports research into Ebola through the UK Research Councils who support a number of research projects addressing different aspects of the disease. This includes work on vaccines, treatments and interventions, and finding a cure.</p><p> </p><p>Current Medical Research Council (MRC) funded research includes a £2.8m grant funding jointly by the MRC, the Wellcome Trust and DFID to allow a team led by the University of Oxford to test the safety of a candidate vaccine alongside similar trials in the US.</p><p> </p><p>The MRC Centre for Outbreak Analysis and Modelling, at Imperial College London, is an official WHO Collaborating Centre for Infectious Disease Modelling. Researchers there have been providing advice to the WHO regarding the current Ebola outbreak in West Africa and contributed to a study reviewing data since the beginning of the outbreak in December 2013 to determine the scale of the epidemic, better understand the spread of the disease, and explore what it will take to reverse the trend of infections.</p><p> </p><p>The Economic and Social Research Council (ESRC) is supporting one £3.6m study which aims to improve our understanding of the cultural and political dimension to inform interventions. In addition researchers funded by the Science and Technology Facilities Council (STFC) are using the Diamond Light Source to investigate emerging viruses are making an Ebola protein for therapeutic antibodies. The Diamond Light Source is the UK’s national synchrotron and is also funded by STFC.</p><p> </p><p>The UK is also a member of the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis, malaria and other neglected diseases, including Ebola. In December 2014 the second phase of the partnership, EDCTP2 was launched aiming to contribute over 1billion euros over the next 10 years. Further information can be found at: <a href="http://www.edctp.org/" target="_blank">http://www.edctp.org/</a></p><p> </p> question first answered 09/12/2014 14:19:58 answering member 4020 label Biography information for George Freeman
	creator	3929 label Biography information for Simon Kirby
	publisher	25259
	tabling member	3929 label Biography information for Simon Kirby